BioNTech/Pfizer Covid vaccine triggers ‘robust’ response in younger children
Published
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Full ArticlePublished
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Full ArticleThe vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up, has been shown to induce a..
Pfizer says its COVID-19 vaccine is safe and effective for 5-11-year-olds. The company said trials showed the vaccine was safe,..